Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Open Lending Corporation regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's financial performance and risk-based pricing models [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from February 24, 2022, to March 31, 2025 [3]. - Allegations include: - Misrepresentation of the capabilities of the company's risk-based pricing models [3]. - Issuance of materially misleading statements regarding profit share revenue [3]. - Failure to disclose that the 2021 and 2022 vintage loans were worth significantly less than their outstanding loan balances [3]. - Misrepresentation of the underperformance of the 2023 and 2024 vintage loans [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 30, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated the company's stock [5].

Concentrix Corp. CNXC released its second-quarter results after Thursday's closing bell. Here's a look at the details in the report. The Details: Concentrix reported quarterly earnings of $2.70 per share, which missed the analyst consensus estimate of $2.75. Quarterly revenue came in at $2.42 billion, which beat the Street estimate of $2.38 billion.Read Next: AST SpaceMobile Stock Downgraded, Rocket Lab Prepares Electron Launch: Space Stock Countdown“In the second quarter, we continued to outperform expecta ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Bitfarms Ltd. regarding a class action lawsuit due to alleged misleading statements and deficiencies in financial reporting [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from March 21, 2023, to December 9, 2024 [3]. - Allegations include that Bitfarms maintained deficient internal controls over financial reporting, misclassified cash flows from the sale of digital assets, and overstated its ability to remediate material weaknesses in its internal controls [3]. Financial Misstatements - The company is accused of misstating various items in its previously issued financial statements, which may require restatement [3]. - As a result of these errors, the public statements made by the company were materially false and misleading throughout the relevant period [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 8, 2025, to participate in potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated the company's stock [5].

Bright Mountain’s consumer insights and analytics company, Big Village, now offers consumr.ai-powered AI twins that interact with consumer cohorts in real time. Boca Raton, FL, June 26, 2025 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (Bright Mountain/OTCQB: BMTM), a marketing services platform company that empowers brands, agencies and publishers to go further, faster, announced that Big Village, a leading provider of consumer insights and analytics, and consumr.ai, the premier AI twin and intelligence ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/west-pharmaceutical-services-inc-loss-submission-form/?id=154297&fr ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE). Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=154294&from=3 CLASS PERIOD: Ju ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Red Cat Holdings, Inc. (NASDAQ: RCAT). Shareholders who purchased shares of RCAT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/red-cat-holdings-inc-loss-submission-form/?id=154295&from=3 CLASS PERIOD: M ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Rocket Companies, Inc. (NYSE: RKT). Shareholders who purchased shares of RKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/rocket-companies-inc-loss-submission-form/?id=154293&from=3 CLASS PERIOD: March ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

Group 1 - Altimmune, Inc. (NASDAQ: ALT) is competing in the metabolic disease drug development sector against major pharmaceutical companies like Novo Nordisk (NVO) and Eli Lilly (LLY) [1] - The article highlights the significance of innovative companies in developing breakthrough therapies and pharmaceuticals that have potential acquisition catalysts [1] Group 2 - The author of the article is a full-time healthcare investor with a focus on biotech and life-saving therapies, emphasizing the importance of understanding the market dynamics in this sector [1]